Schonfeld Strategic Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,733
Closed -$236K 2311
2021
Q2
$236K Buy
+3,733
New +$214K ﹤0.01% 1592
2020
Q3
Sell
-28,937
Closed -$1.27M 1511
2020
Q2
$1.27M Buy
+28,937
New +$1.3M 0.03% 542
2020
Q1
Sell
-12,400
Closed -$582K 1334
2019
Q4
$582K Sell
12,400
-10,800
-47% -$418K 0.01% 689
2019
Q3
$819K Sell
23,200
-18,600
-44% -$644K 0.02% 518
2019
Q2
$1.63M Sell
41,800
-63,500
-60% -$2.56M 0.06% 335
2019
Q1
$4.66M Sell
105,300
-13,600
-11% -$517K 0.16% 167
2018
Q4
$4.15M Buy
118,900
+43,900
+59% +$1.39M 0.16% 177
2018
Q3
$2.75M Sell
75,000
-25,000
-25% -$766K 0.12% 229
2018
Q2
$2.66M Buy
+100,000
New +$2.13M 0.14% 226

Other funds holding KIDS

Schonfeld Strategic Advisors's KIDS Position: Q3 2021 in Review

Schonfeld Strategic Advisors sold out of OrthoPediatrics (KIDS) in Q3 2021, closing a stake of 3,733 shares — an estimated $236K sold.

Schonfeld Strategic Advisors first reported a position in KIDS in Q2 2018 and held it in 9 quarters. The position peaked at $4.66M in Q1 2019. 143 funds tracked by Wall St. Rank hold KIDS as of Q3 2021.

  • Schonfeld Strategic Advisors reported no remaining OrthoPediatrics position as of Q3 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 3,733 OrthoPediatrics shares in Q3 2021, an estimated $236K.
  • Schonfeld Strategic Advisors first reported a position in OrthoPediatrics in Q2 2018 and held it in 9 quarters.
  • Schonfeld Strategic Advisors's OrthoPediatrics position peaked at $4.66M in Q1 2019.
  • 143 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.